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Teratomas are a unique class of tumors composed of ecto-, meso- and endodermal tissues, all foreign to
the site of origin. In humans, the most common teratoma is the ovarian teratoma. Not much is known
about the molecular and genetic etiologies of these tumors. Female carriers of the Tgkd transgene are
highly susceptible to developing teratomas. Ovaries of Tgkd/þ hemizygous female mice exhibit defects
in luteinization, with numerous corpora lutea, some of which contain central trapped, fully-grown
oocytes. Genetically, Tgkd teratomas originate from mature oocytes that have completed meiosis I,
suggesting that Tgkd teratomas originate from these trapped oocytes. The insertion of Tgkd 3’ of the
Inpp4b gene is associated with decreased expression of Inpp4b and changes in intracellular PI3 Kinase/
AKT signaling in follicular granulosa cells. Because Inpp4b is not expressed in fully-grown wild-type or
Tgkd oocytes, these ﬁndings suggest that hyperactivation of the PI3K/AKT pathway caused by the
decrease in INPP4B in granulosa cells promotes an ovarian environment defective in folliculogenesis
and conducive to teratoma formation.
& 2012 Elsevier Inc. All rights reserved.Introduction
Ovarian teratomas (OTs) are tumors of the ovary derived from
non-ovulated female germ cells that have undergone parthenoge-
netic activation and display a disorganized pattern of cellular
differentiation (Linder et al., 1975; Ulbright, 2005). Human OTs are
relatively common, constituting 95% of all ovarian germ cell
tumors (Ulbright, 2005). Most OTs are benign but a small percen-
tage (1–2%) transform into malignant tumors (Schmid-Braz et al.,
2002). OTs contributed to 1.5% of the invasive ovarian cancer cases
in the United States between 2004 and 2008 (Howlader et al.,
2011). OTs are also seen at a low frequency in other mammalian
species, including the mouse (Stevens and Varnum, 1974). Most
OTs are benign and are composed of differentiated ecto, meso and
endodermal tissues, proportions varying from teratoma to tera-
toma. Immature OTs contain undifferentiated cells (primarily
immature neuroepithelium or embryonal carcinoma cells) in
addition to the differentiated tissues and have malignant
potential.
Human OTs originate from oocytes at all meiotic stages, although
most develop from oocytes that have completed meiosis I (Carritt
et al., 1982; Deka et al., 1990; Muretto et al., 2001; Parrington et al.,
1984; Surti et al., 1990; Hoffner et al., 1992). Rarely, benign cysticll rights reserved.
haillet).ovarian teratoma and speciﬁc malignant germ cell tumor cases have
been observed within families, suggesting one or more underlying
genetic etiologies (Blake and Gerrard, 1993; Brenner and Wallach,
1983; Indinnimeo et al., 2003; Plattner and Oxorn, 1973; Simon et al.,
1985; Stettner et al., 1999). However, the majority of OTs occur
sporadically. No associations with known genetic loci have been
established in either familial or sporadic OT cases. The absence of a
clear genetic association raises the possibilities that mutations in
many different genes can cause OTs or that non-genetic etiologies are
common.
Mouse strains predisposed to developing OTs have provided
insight into their development. LT/Sv is an inbred mouse strain in
which approximately 50% of the females develop OTs by 90 days of
age (Stevens and Varnum, 1974). These OTs originated from parthe-
nogenetically activated oocytes that have completed meiosis I (Eppig
et al., 1977). LT/Sv oocytes experience a prolonged period of meiotic
arrest at metaphase I (MI) (O’Neill and Kaufman, 1987). This arrest
(delayed metaphase to anaphase I transition) has been linked to the
sustained activity of maturation promoting factor (MPF), a complex
of CDK1 and cyclin B (Hampl and Eppig, 1996). Normally, a decrease
in MPF activity is required for resumption of meiosis I, and sustained
MPF activity and MI arrest may predispose unfertilized LT/Sv oocytes
to spontaneous cell division (parthenogenesis) and OT formation.
Prolonged metaphase I arrest and parthenogenetic activation of
oocytes have been reported to be necessary but not sufﬁcient for
OT formation (Eppig et al., 1996). Other requirements for OT
formation have been revealed in an analysis of crosses between
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including a prominent locus (Ots1) on chromosome 6 (Lee et al.,
1997).
Targeted mutagenesis in mice has also produced mouse strains
susceptible to developing OTs. The c-mos gene encodes the
cytostatic factor responsible for metaphase II arrest. Conse-
quently, oocytes of homozygous c-mos-null mice fail to maintain
metaphase II arrest and spontaneously initiate parthenogenetic
embryonic development in the absence of fertilization. Approxi-
mately 40% of c-mos-null mice develop OTs (Colledge et al., 1994;
Hashimoto et al., 1994). Mutations in the coding region of the
human c-MOS gene have not been reported, suggesting that
mutations in the c-MOS gene do not play a role in the genesis of
human OTs (De Foy et al., 1998). The MommeR1 mouse strain
with a missense mutation in the transcription factor Foxo3a is
predisposed to developing OTs; one-sixth of homozygous Mom-
meRI females develop OTs (Youngson et al., 2011). The missenseFig. 1. Premature corpora lutea formation and luteinized unruptured follicles were o
follicles in the OT susceptible Tgkd strain compared to wildtype mice (n46 ovaries)
postnatal day 30 (PD30) but not in wildtype wildtype PD30 mice (n¼6) (Scale bar: 200
contained oocytes trapped inside the corpora lutea (scale bar in upper panels 200 mm;mutation was found to cause a decrease in the transactivation
potential of the transcription factor FOXO3A. Notably, both
FOXO3A and c-MOS proteins are primarily expressed in the
oocyte, with little expression in somatic cells of the ovary
(Goldman et al., 1987; John et al., 2008).
Genetic defects in genes expressed in follicular granulosa cells
(GCs), but not in oocytes, also lead to OT formation in mice. One ﬁfth
of mFshrD580H transgenic mice expressing a constitutively active form
of the follicle-stimulating hormone (FSH) receptor in GCs develop OTs
(Peltoketo et al., 2010). Similarly, overexpression of the Bcl-2 gene in
mouse GCs led to a 20% incidence of OTs (Hsu et al., 1996). Hence
alteration in normal cell signaling within the GCs can predispose to
OTs. Transgenic mice expressing small interfering RNAs (siRNAs)
targeting the Gata4 (siGata4) gene also developed OTs (Thurisch et al.,
2009). In the mouse ovary GATA4 is primarily expressed in GCs
(Heikinheimo et al., 1997). Although the mechanism of OT formation
in this model is presently unknown, it is possible that a decrease inbserved in OT susceptible Tgkd mice. (A) Classiﬁcation and numbers of ovarian
. (B) Corpora lutea formation was observed in the Tgkd strain (n¼10 ovaries) at
mm). (C) The ovaries of Tgkd mice exhibited unruptured lutenized follicles, which
scale bar in lower panels 100 mm). *—po0.05.
A. Balakrishnan, J.Richard Chaillet / Developmental Biology 373 (2013) 118–129120granulosa-cell GATA4 indirectly inﬂuences oocyte function, leading to
OT formation. Taken together, the molecular and functional abnorm-
alities observed in the various OT mouse models suggest that several
distinct cell-signaling or cell-cycle defects in cells of the ovarian
follicle can mediate OT development.
We have previously reported that 15–20% of hemizygous female
carriers of the imprinted Tgkd transgene develop OTs in the inbred
FVB/N (FVB) strain (Fafalios et al., 1996). OTs in the FVB-Tgkd strain
have a malignant mixed germ cell phenotype (teratocarcinoma) with
evidence of metastases to the mesenteric lymph node and lung.
Because numerous other transgenic mouse lines with the same or
related imprinted trangenes did not develop ovarian teratomas, we
postulated that the development of OTs in FVB-Tgkd females is due to
disruptions in one or more genes near the genomic site of transgene
integration on mouse chromosome 8. We also observed that hemi-
zygous Tgkd mice developed OTs only on the FVB strain and linkage
analysis mapped the FVB-speciﬁc modiﬁer locus to chromosome 6
(Eicher et al., manuscript in preparation). In this study, we examined
the genetic and molecular effects of the Tgkd transgene on OT
formation in FVB-Tgkd (henceforth designated Tgkd) mice.Results
Abnormal ovarian follicle development in Tgkd mice
We ﬁrst examined ovaries of Tgkd mice for defects in follicu-
logenesis, previously reported in other OT susceptible strainsFig. 2. OTs arise from mature oocytes that have completed meiosis 1. (A) Heterozygou
from the cross between F1 (FVB-Tgkd X C57BL/6) and FVB mice. Genotypes (heterozyg
OTs. (B) Parthenogenetic activation and development to 2-cell stage was examined
(37 cumulus-oocyte complexes from 4 females).(Peltoketo et al., 2010; Youngson et al., 2011). Follicles were
typed using the Pedersen and Peters (1968) method of follicle
classiﬁcation. The distribution of follicle types differed in pre-
pubertal (23 days after birth or PD23) wildtype (FVB) and Tgkd
mice, although the total number of activated follicles was not
signiﬁcantly different. Absolute numbers of primary (Type
3b—one layer of cuboidal GCs) and secondary (Type 4–two layers
of GCs) follicles were similar in wildtype and Tgkd ovaries, but
there were twice the number of preantral (Type 5–three or more
layers of GCs) follicles in Tgkd ovaries (Fig. 1A). This was
accompanied by a decrease in the absolute number of early and
late antral (Type 6–8) follicles per ovary. Similar defects in
folliculogenesis were seen in post-pubertal PD30 Tgkd female
mice. Speciﬁcally, we observed a 1.6-fold increase in the number
of preantral follicles in PD30 Tgkd mice, which was accompanied
by a 0.4-fold decrease in the number of antral follicles (Fig. 1A).
PD30 Tgkd ovaries showed additional follicular defects, not
present in age-matched wildtype mice, which are indicative of
perturbed follicle maturation. An average of 4.4 corpora lutea
were observed, whereas no corpora lutea were observed in
control wildtype mice (Fig. 1B). In addition, trapped oocytes were
observed in many PD30 Tgkd corpora lutea (Fig. 1C); one exam-
ined ovary contained four corpora lutea with trapped oocytes.
A corpus luteum is formed from the remnants of the follicle after
ovulation of the oocyte; hence a trapped oocyte indicates that the
follicle has luteinized prior to ovulation of the oocyte. These
luteinized, unruptured follicles are a further indication of defec-
tive ovarian follicle maturation in Tgkd mice, and the associateds pericentric and distal SNPs were identiﬁed in the spleens of 7 females with OTs
ous or homozygous FVB) of these SNPs was then determined in each of the paired
in wildtype (43 cumulus-oocyte complexes from 4 females) and Tgkd oocytes
Fig. 3. Role of Tgkd transgene methylation in OT formation in the Tgkd strain.
(A)Methylation of RSV region of Tgkd in MII oocytes (from 4 Tgkdmice), teratomas
(from 2 Tgkd mice) and MII oocytes (from 2 Tgkd, Dnmt3l / mice). (B) The OT
phenotype is present in 15% of Tgkd hemizygous females but is lost in the Dnmt3l
 / background. *—p valueo0.05.
Fig. 4. Schematics of Tgkd transgene insertion site on chromosome 8. (A) The Tgkd
allele is inserted on chromosome 8 as a transgene tandem array in head–head,
tail–tail or head–tail orientation. Each arrow represents a single copy of the
transgene. (B) Structure of the modiﬁed RSVIgmyc transgene used to generate the
Tgkd line. (C) PCR analysis was used for genotyping the Tgkd transgene in the Tgkd
strain. Lane 1 represents a mouse sample without the transgene, lane 2 represents
a hemizygous Tgkd DNA sample and lane 3 represents a homozygous Tgkd DNA
sample.
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Despite the observed abnormalities in Tgkd ovary morphology,
there was no evidence of a signiﬁcant reduction in the fertility of
hemizygous Tgkd females, and no differences in primordial follicle
numbers between wildtype and Tgkdmice at both PD23 and PD30
(Supplementary Fig. 1A and B). Consequently there was no
evidence of premature ovarian failure (POF), which is associated
with OT formation in other mouse strains (Peltoketo et al., 2010,
Youngson et al., 2011). In addition, female Tgkd mice attained
puberty at post-natal day 28 (PD28), the same day on which
control wildtype female mice reached puberty (data not shown).
This latter observation is consistent with normal gonadotrophin
signaling during puberty in Tgkd female mice.
Tgkd oocytes complete meiosis I prior to forming OTs
Both follicle luteinization and meiotic maturation of fully-
grown oocytes require luteinizing hormone (LH) (Hsieh et al.,
2007). Therefore, if Tgkd OTs originate from oocytes trapped in
corpora lutea we might expect them to have completed meiosis I.
Using a single Tgkd transgene ﬂanking DNA fragment (38 cM
from centromere) for genotyping, we previously reported hemi-
zygous Tgkd genotypes in 5 OTs from hemizygous FVB-Tgkd
female mice, suggesting a pre-meiotic origin of Tgkd OTs
(Fafalios et al., 1996). However, this was an inconclusive study
because of the use of a single heteromorphic marker located
38 cM from the centromere of chromosome 8 (Fafalios et al.,
1996). To more deﬁnitively determine the cellular etiology of Tgkd
OTs, we studied genomic DNA samples from Tgkd OTs and paired
host spleens obtained from Tgkd transgenic offspring of F1 (FVB-
Tgkd  C57BL/6) hybrid male mice backcrossed to inbred FVB
female mice (Eicher et al., manuscript in preparation). Genotypes
of paired OT and spleen DNA samples were compared using
pericentric and distal single nucleotide polymorphisms (SNPs)
between FVB and C57BL/6 (B6) strains for each autosome and the
X chromosome. For the majority of informative (heterozygous
FVB/B6) pericentric markers in each spleen DNA sample, geno-
types of the paired OT DNA sample were homozygous (Fig. 2A,
Supplementary Table 1). In contrast, the majority of the informa-
tive distal SNPs in each spleen DNA sample remained hetero-
zygous in the OT, consistent with frequent meiotic recombination
between a distal SNP marker and the centromere of the same
chromosome. The small number of pericentric SNPs that were
heterozygous in both paired OT and spleen DNA was likely due to
a low frequency of recombination events near the centromere.
We conclude from these ﬁndings that each of the seven examined
Tgkd OTs originated from a single mature oocyte that had
completed meiosis I.
Parthenogenetic activation of Tgkd oocytes
Parthenogenetic activation of oocytes has been reported to
play a prominent role in the development of OTs (Colledge et al.,
1994; Hashimoto et al., 1994; Stevens and Varnum 1974). Given
this, we measured spontaneous parthenogenetic activation in
cultured unfertilized Tgkd oocytes by measuring the frequency
of oocytes that progressed to the 2-cell stage (Eppig et al., 1996).
Approximately 30% of cultured Tgkd oocytes underwent cell
division, similar to the percentage of 2-cell embryos seen in
cultured wildtype oocytes (Fig. 2B). This rate of parthenogenetic
activation of FVB oocytes is much greater than that of B6 oocytes
(Eppig et al., 1996), suggesting that mature oocytes in inbred FVB
mice have a propensity toward parthenogenetic activation. The
absence of OTs in inbred FVB female mice however indicates that
the FVB strain background alone is not sufﬁcient for OT formation.Role of oocyte Tgkd methylation in formation of OTs
Because the Tgkd transgene is maternally imprinted in Tgkd
mice (Chaillet et al., 1995), we determined whether loss of Tgkd
transgene methylation inﬂuenced the formation of Tgkd OTs. The
Rous sarcoma virus (RSV) sequences of Tgkd are methylated on
the maternal and unmethylated on the paternal Tgkd alleles
(Chaillet et al., 1995). RSV sequences were highly methylated in
Tgkd Dnmt3lþ /þ metaphase II arrested (MII) oocytes (82%) and
Tgkd OTs (84%), but poorly methylated in Tgkd Dnmt3l/ MII
oocytes (26%) (Fig. 3A). These ﬁndings are consistent with the
known role of the DNMT3L protein in the establishment of
genomic methylation, including imprinted methylation, during
Fig. 5. Expression of Inpp4b in Tgkd embryos. (A) Inpp4b total transcript and levels
of a and b isoforms were measured in homozygous and hemizygous Tgkd E13.5
embryo heads (þ/þ—wildtype; Tgkd(m)/þ—maternally inherited Tgkd; Tgkd(p)/
þ—paternally inherited Tgkd; and Tgkd/Tgkd—homozygous Tgkd) (n43mice/
genotype). (B) INPP4B protein levels in homozygous and hemizygous Tgkd E13.5
embryo heads (n¼3). *—p value o0.05.
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were found in Tgkd and Tgkd Dnmt3lþ / heterozygous female
mice, but not in Tgkd, Dnmt3l / female mice (Fig. 3B). These
ﬁndings support the notion that oocyte genomic methylation, and
possibly speciﬁcally Tgkd transgene methylation, is required for
OT formation in Tgkd female mice.
Integration site of Tgkd transgene
To explore the molecular basis of Tgkd OTs, we identiﬁed the
genomic location into which the Tgkd transgene inserted.
Sequences of the endogenous genomic ends of both junctional
fragments containing endogenous and Tgkd transgene sequences
aligned with sequences on mouse chromosome 8, between the
Inpp4b and I15 genes. Further analysis of the junctional fragments
indicated that approximately one kilobase of endogenous geno-
mic DNA was deleted from the insertion site. The Tgkd transgene
is located 65 kilobases 3’ of the known 3’ end of the inositol
polyphosphate-4-phosphatase type II (Inpp4b) gene and 120
kilobases 5’ of the known 5’ end of the Interleukin 15 (Il5) gene
(Fig. 4A). The location of the large Tgkd transgene array in the
intergenic region of Inpp4b and Il15 suggested that the pheno-
typic abnormalities in Tgkd mice were due to disruption of one or
more unidentiﬁed genes in the intergenic region or due to effects
on Inpp4b and/or Il15 gene function. No spliced or unspliced
transcripts have been reported in the Inpp4b-Il15 intergenic
region and multiple attempts to recover exons in this intergenic
region using exon-trapping strategies failed.
The Tgkd allele is associated with a decrease in Inpp4b expression
Il15 is not likely to play a role in the etiology of OTs because
Il15 is mainly involved in the innate immune response (Ohteki
et al., 2001), and neither Il15/ mice nor mice that overexpress
IL15 have been reported to develop OTs (Kennedy et al., 2000;
Fehniger et al., 2001). We therefore postulate that the phenotypic
abnormalities in Tgkdmice are due to abnormalities in expression
of the Inpp4b gene. Because Inpp4b transcripts are highly
expressed in the brain, we ﬁrst explored the effect of the Tgkd
insertion on Inpp4b transcript and protein levels in the heads of
embryonic day 13.5 (E13.5) embryos (Ferron and Vacher, 2006).
The two main Inpp4b transcripts, Inpp4ba and Inpp4bb are
produced by alternative splicing of the 3’ end of Inpp4b and are
translated into the INPP4Ba and INPP4Bb proteins respectively
(Ferron and Vacher, 2006). A comparison of Inpp4b transcript
levels was performed among Tgkd/Tgkd, Tgkd(mat)/þ (maternal
inheritance), Tgkd(pat)/þ (paternal inheritance) and wild-type E13.5
embryos (Fig. 5A). The level of Inpp4bb was most affected by the Tgkd
insertion; Tgkd/Tgkd and Tgkd(mat)/þ embryos expressed 50% of
wild-type Inpp4bb, whereas Tgkd(pat)/þ embryos showed a 20%
decrease in Inpp4bb expression. Inpp4ba (includes Inpp4bas, a short
a-like transcript) was less affected in Tgkd embryo heads. Homo-
zygous Tgkd/Tgkd embryos showed the most downregulation (20%)
compared to wildtype controls, and Tgkd(mat)/þ embryos had
comparable Inpp4ba expression as Tgkd/Tgkd embryos. Levels of
Inpp4ba in Tgkd(pat)/þ embryos were somewhat lower than wild-
type embryos but this difference was not statistically signiﬁcant. Total
Inpp4b followed a pattern of expression similar to the Inpp4ba
transcript because the level of Inpp4bb was approximately 10-fold
lower than the total levels of Inpp4b in adult brain. INPP4B protein
levels were correspondingly reduced in E13.5 embryonic heads.
Individual Tgkd/Tgkd heads had 50% of the wildtype protein
concentration (Fig. 5B). Individual Tgkd(mat) and Tgkd(pat) heads
had lower concentrations of INPP4B, although collectively, levels of
INPP4B in hemizygous mice were not statistically different than wild-
type mice (Fig. 5B). The combination of small effects on the normallyhighly expressed Inpp4ba transcripts, and large effects on the
normally poorly expressed Inpp4bb transcript from both parental
Tgkd alleles accounts for the signiﬁcant differences in INPP4B expres-
sion between Tgkd/Tgkd and control wildtype embryos. Because there
was no signiﬁcant effect of Tgkd parental origin on INPP4B protein
expression, we did not distinguish Tgkd(mat) from Tgkd(pat) female
mice in studies of effects of the Tgkd transgene in the ovary.
RNA in situ hybridization (ISH) was used to determine the
location of Inpp4b transcripts. As shown in Fig. 6A, the Inpp4ba,
but not the Inpp4bb isoform was expressed in the ovary and this
expression was conﬁned to GCs. No expression was observed in
oocytes. These ﬁndings were conﬁrmed in measurements of
individual Inpp4b transcripts in isolated GCs and oocytes in
PD30 wildtype and Tgkd mice (Fig. 6B). The surprising ﬁnding
that ovarian Inpp4b expression is conﬁned to GCs raises the
possibility that the Tgkd insertion facilitates OT formation by
altering INPP4B expression in GCs, which in turn alters follicular
development and possibly normal GC-oocyte interactions. In
addition, Inpp4b expression is known to be responsive to andro-
gens (Hodgson et al., 2011). For these reasons, we examined the
effect of Tgkd on INPP4B levels in ovarian cells exposed to
hormonal stimuli. No difference in expression of Inpp4b was
observed between PD23 wildtype and Tgkd ovaries (Fig. 6C).
Synchronized in vivo maturation of wildtype and Tgkd ovarian
follicles was initiated with gonadotrophins (one-time IP injection
of pregnant mare serum gonadotrophin (PMSG)), followed by
induction of ovulation with a one-time injection of human
chorionic gonadotropin (HCG). Levels of Inpp4b in wildtype mice
ﬂuctuated over the 48-hour time course of PMSG stimulation and
2 h of HCG stimulation. The Tgkdmice show a 20% decrease in the
level of Inpp4b transcript compared to the wildtype mice at 24
and 38 h after PMSG stimulation (Fig. 6C). A slightly larger
difference was seen between wildtype and Tgkd ovaries 48 h after
Fig. 6. Inpp4b expression in the wildtype and Tgkd ovaries. (A) Inpp4b a and b isoform expression in the ovarian follicle measured by in situ hybridization in 7-week old
wildtype ovaries. Top right panel: Oocyte speciﬁc probe: Slc39a10 to depict oocyte speciﬁc staining. Lower right panel: Small Intestine as positive control for Inpp4bb probe
(B) Real-time PCR quantitation of Inpp4b in GCs and oocytes in PD30 wildtype and Tgkd ovaries: UD–Undetected. (C) Real-time PCR quantitation of Inpp4b (Inpp4ba) in
wildtype and Tgkd ovaries during the course of PMSG stimulation (n43 mice/time point). (D) INPP4B protein levels in wildtype and Tgkd ovaries during PMSG stimulation
(n¼3). (E) Measurement of INPP4B protein on enriching the GCs in culture (n¼3). *—p value o0.05.
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levels of Inpp4b.
The Tgkd transgene also affected levels of ovarian INPP4B protein.
INPP4B levels in lysates of whole ovaries ﬂuctuated slightly during
the time course of PMSG stimulation. The largest difference, a 50%
decrease of INPP4B in Tgkd ovaries (po0.05), was recorded 38 h after
PMSG stimulation (Fig. 6D). At other time points during PMSG
stimulation, the levels of INPP4B were comparable in wildtype and
Tgkd mice. A more pronounced effect of the transgene on INPP4B
expression was observed in puriﬁed and in-vitro cultured GCs;
INPP4B was signiﬁcantly downregulated to a higher extent in
cultured unstimulated PD23 Tgkd GCs (70% of wildtype GCs) and
following 10min of FSH administration (Fig. 6E). This method of
enriching for GCs excluded the ovarian capsule and stroma, which
expressed low levels of Inpp4b (Supplementary Fig. 1D and E).
Tgkd affects PI3K/AKT signaling in ovarian follicles
Because Inpp4b has been implicated in the control of intracel-
lular PI3-Kinase/AKT (PI3K/AKT) signaling (Fig. 7A; Gewinneret al., 2009; Fedele et al., 2010; Hodgson et al., 2011), we studied
the effects of the Tgkd transgene on PI3K/AKT signaling in the
ovary. Whole ovaries were collected at different time points
following in-vivo hormonal stimulation, and the time course of
phosphorylated AKT (P-AKT), an indication of PI3K/AKT pathway
activation, and its downstream effects were measured. P-AKT
levels were roughly similar in immature PD23 wildtype and Tgkd
ovaries prior to administration of exogenous hormones, but
signiﬁcant differences were evident following 14 and 24 h of
PMSG stimulation (po0.05) (Fig. 7B; quantiﬁed in Supplemen-
tary Fig. 3A). Corresponding differences in levels of phosphory-
lated FOXO1 (P-FOXO1), a downstream target of P-AKT (Fig. 7A)
speciﬁcally in GCs, were also evident (Fig. 7B) (Richards et al.,
2002). Time courses of changes in total FOXO1, E2F1, CyclinD2
and P27 were similar between wildtype and Tgkd ovaries (Fig. 7B).
Following administration of a single dose of HCG 48 h after PMSG
stimulation, P-AKT and P-FOXO1 concentrations declined at a
much faster rate in Tgkd compared to wildtype ovaries (Fig. 7C;
quantiﬁed in Supplementary Fig. 3B). An accentuated rate of
decline in the level of FOXO1 and an accentuated rate of increase
Fig. 7. Activation of the PI3K/AKT pathway in Tgkd ovaries. (A) Pathway depicting regulation of INPP4B on Phospho-AKT activation and its downstream targets.
(B) Dynamics of the PI3K/AKT pathway was measured in wildtype and Tgkd ovaries in immature mice and on PMSG stimulation by investigating the levels of P-AKT,
P-FOXO1, FOXO1, E2F1, Cyclin D2 and P27 (n¼3 mice/time point; ovaries from single female per lane). (C) After 48 h of PMSG stimulation; the mice were injected with
HCG and the activation of the PI3K/AKT pathway was surveyed (n¼3). (D) The dynamics of P-AKT phosphorylation was examined in wildtype and Tgkd oocytes (20
oocytes/lane). (E) P-AKT and P-FOXO1 activation were measured after FSH stimulation in cultured GCs from wildtype and Tgkdmice (n¼3). (F) Lentiviral mediated shRNA
downregulation of Inpp4b in wildtype GCs led to the activation of the PI3-kinase pathway similar to the levels seen in Tgkd GCs (n¼3).
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HCG stimulation were also evident (Fig. 7C). We conclude from
this experiment that the presence of the Tgkd transgene 3’ of the
Inpp4b gene augments the response of mature ovarian follicles to
stimuli known to mimic endogenous ovulatory stimuli, leading to
premature phosphorylation of the AKT protein and activation of
downstream effectors of the PI3K/AKT signaling pathway.
The pattern of P-AKT activation following gonadotropin
administration was investigated in wildtype and Tgkd oocytes.
There was no difference in the P-AKT activation and phosphor-
ylation of its downstream target FOXO3A between wildtype and
Tgkd oocytes during the time course of gonadotrophin stimulation
(Fig. 7D). These ﬁndings are consistent with the observed absence
of Inpp4b expression in fully-grown oocytes (Fig. 6).
Collectively, the observed effects of the Tgkd transgene on
ovarian and oocyte AKT signaling are consistent with effects of
Tgkd on PI3K/AKT signaling in GCs. To directly test this postulate,
we obtained puriﬁed GC pools and stimulated them with FSH.
Tgkd GCs from PD23 ovaries had a lower level of INPP4B than
wildtype GCs (Fig. 6E). Tgkd GCs also had a slightly higher level of
P-AKT and P-FOXO1 after overnight culture in medium containing
10% FBS (Fig. 7E; quantiﬁed in Supplementary Fig. 4). Tgkd GCs
did not show the decline in P-AKT levels seen in wildtype GCs
after 40 min of FSH stimulation (Fig. 7E; quantiﬁed in Supple-
mentary Fig. 4). We independently investigated this inverse
relationship between INPP4B levels and AKT pathway activation
in GCs infected with lentiviruses expressing shRNAs to the mouse
Inpp4b gene. Two independent shRNA constructs were used, and
expression of both constructs resulted in 50% reduction in the
levels of INPP4B compared to controlled uninfected wildtype GCs
(Fig. 7F). Corresponding increases in the levels of P-AKT and
P-FOXO1 were seen prior to and 40 min after FSH administration.These results conﬁrm the relationship between INPP4B and PI3K/
AKT signaling observed in Tgkd GCs. Notably, not all Tgkd cells
show a decrease in the level of INPP4B and augmented effects on
PI3K/AKT signaling following stimulation. For example, hemizy-
gous and homozygous Tgkd ES cell lines derived from Tgkd
embryos did not show a consistent decrease in steady-state
INPP4B levels and effects of Tgkd on the PI3K/AKT signaling
pathway were not evident upon standard stimulation with IGF1
(Supplementary Fig. 2).Proliferation and apoptosis of GCs were altered in Tgkd ovaries
Downstream effectors of AKT activation have been shown to
induce cell proliferation and block apoptosis (Manning and
Cantley, 2007). Cyclin D2 promotes G1/S phase transition and
increase cell proliferation, and FOXO1 is known to promote
cellular apoptosis (Sherr, 1995; Huang and Tindall, 2007). Because
the levels of P-AKT and downstream targets FOXO1 and Cyclin D2
in the ovary are inﬂuenced by Tgkd (Fig. 7C), we compared rates of
cell proliferation and apoptosis in preantral and antral follicles of
Tgkd and wildtype female mice (Fan et al., 2008a, 2008b). There
was a signiﬁcant 1.8-fold increase in the rate of GC proliferation
in PD30 Tgkd ovaries (Fig. 8A). The rate of apoptosis in Tgkd
ovaries was also signiﬁcantly reduced to approximately 50% of
the rate seen in wildtype ovaries as measured by cleaved caspase
3 staining at 2 h after HCG stimulation (Fig. 8B). FOXO1 localiza-
tion was similar in follicles of wildtype and Tgkd PD30 ovaries
(Supplementary Fig. 5). These results further reinforce the notion
that follicle maturation is perturbed in Tgkd ovaries through the
premature phosphorylation of AKT and FOXO1 in GCs, and
imbalances in rates of cellular proliferation and apoptosis.
Fig. 8. Hyperactivation of the PI3K/AKT pathway in Tgkd ovaries leads to an increase in proliferation and decrease in apoptosis in Tgkd GCs. (A) Quantiﬁcation of rate of
granulosa cell proliferation in PD30 wildtype and Tgkd follicles measured by bromodeoxyuridine (BrdU) staining (n¼25 follicles). (B) Quantiﬁcation of rate of granulosa
cell apoptosis in wildtype and Tgkd follicles measured by Cleaved Caspase 3 (CC3) staining (n¼25 follicles). *—p value o0.05.
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Altered kinetics of the PI3K/AKT pathway leads to OT development
Inpp4b is a recently identiﬁed suppressor of the PI3K/AKT
signal transduction pathway that has not been studied previously
in the ovary (Gewinner et al., 2009; Fedele et al., 2010; Hodgson
et al., 2011). Inpp4b is an inositol-polyphosphate-4-phosphatase,
whose main substrate is phosphatidylinositol-3,4-bisphosphate
(PI(3,4)P2), which it dephosphorylates to phosphatidylinositol-3-
phosphate PI(3)P. Because PI(3,4)P2 stimulates AKT phosphoryla-
tion, a decrease in Inpp4b levels has been linked to increased AKT
activation and the progression of breast, ovarian and prostate
cancer (Gewinner et al., 2009; Fedele et al., 2010; Hodgson et al.,
2011). In this study, we established a link between PI3K/AKT
signaling and OT development in Tgkd mice by showing that low
levels of this novel inositol phosphatase in follicular granulosa
cells (GCs) leads to the development of OTs. Speciﬁcally, a
decrease in Inpp4b levels in GCs during gonadotrophin stimula-
tion is associated with hyperactivation of the PI3K/AKT pathway,
which is reﬂected by an increase in AKT phosphorylation and
subsequent FOXO1 phosphorylation in Tgkd GCs. The hyperacti-
vation of the PI3K/AKT pathway is accompanied by an increase in
proliferation and decrease in apoptosis in Tgkd GCs. These
changes lead to multiple defects in folliculogenesis including an
increase in preantral follicles and premature appearance of
corpora lutea in Tgkd mice. Moreover, a subset of lutenized
follicles in Tgkd ovaries contain mature oocytes trapped within
them, and the oocytes of the FVB strain have a high parthenoge-
netic activation rate, independent of the Tgkd transgene. We
speculate that the combination of luteinized unruptured follicles
observed in the Tgkd strain resulting from Inpp4b reduction in GCs
and the high innate parthenogenetic activation rate of FVB
oocytes predispose Tgkd mice to OTs.
PI3K/AKT is an essential signal transduction pathway in the
ovary, involved in follicle recruitment and induction of many
important FSH-mediated follicular maturation events including
GC proliferation, differentiation, cumulus cell expansion, andmeiotic resumption of oocytes (Zeleznik et al., 2003; Shimada
et al., 2003; Hoshino et al., 2004; Kalous et al., 2006; Han et al.,
2006). Studies of mouse PTEN, a better characterized suppressor
of the PI3K/AKT pathway than INPP4B, nicely illustrate the
diverse cellular roles of this important intracellular signaling
pathway. Ablation of the Pten gene in oocytes leads to premature
follicle recruitment and ovarian failure leading to infertility in
early adulthood, while deletion of both Pten alleles in GCs results
in enhanced GC proliferation, decreased GC apoptosis, persistence
of multiple corpora lutea and unexpected increases in litter size
(Reddy et al., 2008; Fan et al., 2008a). Pten and Inpp4b suppress the
PI3K/AKT pathway by degrading PI(3,4,5)P3 and PI(3,4)P2 respectively,
the chief activators of AKT (Fig. 7; Maehama and Dixon, 1998; Norris
et al., 1997; Gewinner et al., 2009). Tgkd GCs with decreased Inpp4b
levels show a similar increase in proliferation and decrease in
apoptosis to that observed in GCs depleted of PTEN, but the rate of
corpora lutea clearance in Tgkd ovaries was unaffected by the
decrease in Inpp4b levels (Supplementary Fig. 1C).
Molecular events both upstream and downstream of follicular AKT
activation have been previously implicated in OT development.
Forced expression of a constitutively active form of the FSH receptor
(FSHR) from a transgene (mFshrD580H) in GCs causes OTs in 20% of
transgene carriers and FSHR signaling is associated with activation of
the PI3K/AKT pathway (Peltoketo et al., 2010;Gonzalez-Robayna et al.,
2000). Furthermore, a reduction in FOXO3A activity, a downstream
effect of increased AKT activation is associated with OT development
(Youngson et al., 2011). FOXO3A is primarily expressed in oocytes,
not GCs and is phosphorylated by activated AKT, causing its nuclear
exclusion, degradation and loss of its transcriptional activation (John
et al., 2008; Huang and Tindall, 2007). Interestingly, a missense
mutation in the mouse Foxo3a gene in the MommeR1 mouse strain
directly decreases its transcriptional activation, mimicking the effect
of increased oocyte PI3K/AKT pathway activity on FOXO3A, which
causes one out of every six homozygous mutant MommeR1 female
mice to develop OTs (Youngson et al., 2011). In summary, the
mFshrD580H and Tgkd transgenes illustrate the relationship between
hyperactivation of the GC PI3K/AKT pathway and OT formation,
A. Balakrishnan, J.Richard Chaillet / Developmental Biology 373 (2013) 118–129126while the MommeR1 strain illustrates the same relationship, but in
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Effect of Inpp4b levels on OT phenotype
Ovarian phenotypes appear to be exquisitely sensitive to the
cell type and/or extent of gene disruption. For example, while a
decrease in Foxo3a activity in MommeR1 mice causes OTs,
complete loss of oocyte FOXO3A activity is associated with POF,
without the occurrence of OTs (Castrillon et al., 2003). Similarly,
the level of ovarian transgene expression of mFshrD580H correlates
with the severity of the ovarian phenotype (Peltoketo et al., 2010).
Our studies indicate that a small decrease in GC Inpp4b in Tgkd
mice is sufﬁcient to alter AKT activation kinetics in GCs, leading to
a variety of abnormal ovarian phenotypes including OTs. We can
speculate that lesser or greater degrees of INPP4B defects would
produce a different and unique collection of abnormal ovarian
phenotypes, including ones that might preclude OT formation.
Recently an Inpp4b knockout mouse has been generated
through the Cre mediated deletion of exon 11(Ferron et al.,
2011). Adult Inpp4b/ mice are reported to be viable and do
not develop OTs or spontaneous cancers, even though Inpp4b
reduction has been previously linked to the etiology of breast and
prostate cancer (Gewinner et al., 2009; Fedele et al., 2010;
Hodgson et al., 2011). Sustained loss of INPP4B in Inpp4b/
mice may have led to adaptation by other suppressors of the PI3K/
AKT pathway. Further, the mechanism by which the Tgkd trans-
gene causes a decrease in Inpp4b levels is currently unknown. The
insertion could have disrupted an enhancer or changed local
chromatin conﬁguration, which leads to sudden or cell-speciﬁc
changes, preventing adaptation by other components of the
pathway. The insertion could have affected other genes on
chromosome 8, but a preliminary screen did not detect any other
transcriptional differences in genes in a 2 MB region surrounding
the Tgkd transgene. We also have not identiﬁed any sequence
changes in the body of the Tgkd-linked Inpp4b gene nor novel
forms of Inpp4b mRNAs in homozygous Tgkd E13.5 brains.
OT development is a multifactorial process
OT formation has been linked to signaling defects in either
oocytes or in the surrounding follicular GCs. Other OT mouse
models, particularly those with defects in GCs, share aspects of
Tgkd ovarian pathology. The intentional genetic defects in the
mFshrD580H, Inha-bcl2 and siGata4 mouse lines are all conﬁned to
GCs (Peltoketo et al., 2010; Hsu et al., 1996; Thurisch et al., 2009).
Interestingly the mFshrD580H model shows an increase in GC
proliferation, while Inha-bcl2 ovaries display a decrease in GC
apoptosis. Luteinized follicles containing trapped oocytes are seen
in mFshrD580H mice (Peltoketo et al., 2010). All of these processes
are affected in female Tgkd mice, which have a high incidence of
OTs, suggesting that the collective inﬂuence of many altered
follicular processes greatly enhances the likelihood of OT
formation.
We also observed that Tgkd Dnmt3l/ mice did not develop
OTs. Methylation of the Tgkd transgene and all endogenous
maternal methylation imprints should not be established in Tgkd
Dnmt3l/ oocytes (Bourc’his et al., 2001). Because Inpp4b is
expressed in GCs, but not in oocytes, the parental origin of Tgkd,
and hence the extent of its methylation, may not play a role in OT
formation because mice with GCs inheriting Tgkd from either
parent develop OTs (Fafalios et al., 1996). Rather, the requirement
of maternal methylation imprints for OT formation may be due to
the strict requirement of maternal imprints for embryogenesis
(Bourc’his et al., 2001), a process mimicked in the growth and
cellular differentiation of OTs.Because a common feature of many mouse strains developing
OTs is the FVB strain background, we must consider the possibi-
lity that these inﬂuences on OT development are determined by
FVB alleles of other genes. The Tgkd, mFshrD580H, Inha-bcl2 and
MommeR1 strains have been reported to develop OTs on the FVB
background (Fafalios et al., 1996; Peltoketo et al., 2010; Hsu et al.,
1996; Youngson et al., 2011), and FVB oocytes possess a high
parthenogenetic activation rate, which is required for OT forma-
tion (Eppig et al., 1996). In this regard, an FVB-speciﬁc OT
modiﬁer locus has been mapped to chromosome 6, within a
region that overlaps a previously mapped LT/Sv strain-speciﬁc OT
modiﬁer effect (Eicher et al., manuscript in preparation; Lee et al.,
1997). Identiﬁcation of candidate genes within this region that
contribute to the OT phenotype would help better understand the
multifactorial processes involved in the generation of teratomas.
The effect of the FVB strain background may also explain the lack
of the OT phenotype in the Inpp4b/ mice, which were studied
in the C57BL/6 strain background.
In summary, altered regulation of the PI3K/AKT pathway caused
by a decrease in Inpp4b in GCs during follicle maturation leads to a
dramatic increase in the number of GCs. This is associated with
several follicular defects including oocytes trapped within luteinized
follicles. The trapped oocytes caused by the Tgkd transgene combined
with the parthenogenetic oocytes of the FVB strain predispose Tgkd
mice to OT development.Material and methods
Animals
The Tgkd transgene was maintained on the inbred FVB/N (FVB)
background as described previously (Fafalios et al., 1996). All
experiments were performed in compliance with guidelines
established by the Institutional Animal Care and Use Committee
of the University of Pittsburgh. For determining the onset of
puberty, females were examined daily for vaginal opening from
day 22 postpartum.
SNP genotyping of ovarian teratomas (OT)
Spleen and teratoma DNA samples were collected from female
progeny of the backcross of F1 (FVB-Tgkd X C57BL/6) to FVB/N
mice. 20 pericentric and 20 distal SNPs (one per chromosome)
were examined in the spleen DNA for evidence of heterozygosity.
The heterozygous SNPs in the spleen were examined in the
teratoma, in order to determine the last meiotic stage completed
by the oocyte before initiating OT formation (Surti et al., 1990).
Detailed information of SNP locations and sequence in the spleen
and OT are provided in Supplementary Table 1.
Identiﬁcation of Tgkd insertional site
This was accomplished by identifying the two Tgkd-genome
junctional fragments on Southern blots of FVB-Tgkd DNA probed
with fragments of the Tgkd transgene, constructing Tgkd subge-
nomic libraries in the lFixII vector (Stratagene, La Jolla, CA), and
identifying clones containing the two junctional fragments.
Collection of embryos
Crosses were set up between hemizygous Tgkd and wildtype
animals so that the parental origin of the Tgkd transgene was
known. The day on which the plug was observed was noted as day
0.5. Embryonic day 13.5 (E13.5) embryos were collected 13 days
after observation of the plug. E13.5 embryo heads were frozed
A. Balakrishnan, J.Richard Chaillet / Developmental Biology 373 (2013) 118–129 127at 80 1C until RNA extraction or protein extraction. Tail DNA
was isolated from these embryos and used to determine presence
or absence of Tgkd.
Collection of ovaries and oocytes
Whole ovary, germinal vesicle (GV)-stage oocytes and GCs
were collected from immature females (21–23 day post partum)
at designated time points following intra-peritoneal (IP) injection
of 5IU pregnant mare serum gonadotropin (PMSG) (Calbio-
chem—367222 La Jolla, CA) and 5IU of human chorionic gonado-
tropin (HCG) (Sigma—C5297 St Louis, MO) injection. GCs and
oocytes were collected in M2 medium (Millipore-MR-015-D,
Temecula, CA) following needle puncture of the ovaries. The
oocytes were collected and the remaining GCs were pelleted
and lysed in 1 Laemmli sample buffer.
Ovarian morphology was examined in hematoxylin and eosin
(H&E)-stained parafﬁn sections of ovaries ﬁxed overnight in 4%
paraformaldehyde. Follicle counting and classiﬁcation were per-
formed on every ﬁfth adjacent section of 5 mm thickness according
to an established system described by Pedersen and Peters (1968).
Parthenogenetic activation of Tgkd oocytes was examined by
isolating cumulus-oocyte-complexes (COC) from immature PD23
wildtype and Tgkd mice after 48 h of PMSG stimulation. Oocytes
were separated from surrounding cumulus cells after in-vitro
maturation and the frequency of 2-cell embryos was determined
after 24 h of additional culture in KSOM (Embryomax—MR-106-D,
Millipore) as described previously (Eppig et al., 1996).
ES cell derivation and generation of shRNA clones
129-Tgkd(mat) ES lines were derived from 129-Tgkd  129
crosses and 129-Tgkd(pat) ES lines were derived from 129129-
Tgkd crosses. Homozygous Tgkd ES lines were derived from 129-
Tgkd  129-Tgkd crosses. ES cell lines were generated by
collection of E3.5 blastocysts and ES cell lines were established
using previously published methods (Nagy et al., 2003). Stable
knockdown clones of INPP4B were obtained by the electropora-
tion of linearized shRNA plasmid constructs TRCN0000080645
and TRCN0000080646 (Open Biosystems, Huntsville, AL) followed
by isolation of puromycin-resistant colonies. Extent of knock-
down of INPP4B was determined by immunoblot analysis.
IGF1 stimulation protocol
ES cells were passaged twice without feeders and then plated
on 12 well plates coated with 0.1% gelatin. The cells were serum
starved for 34 h and then stimulated with 1 mg/ml of mouse IGF1
(Sigma-I8779) for indicated periods.
Granulosa cell culture
This experiment was performed as described previously with
minor modiﬁcations (Escamilla-Hernandez et al., 2008). This protocol
enables selective enrichment of GCs by isolating and culturing GCs
fromwildtype and Tgkd ovaries and excludes oocytes, and the ovarian
capsule from the analysis. Ovaries were harvested from immature
females (day 21–23 postpartum) and incubated in 6mM EGTA and
0.5 M Sucrose in DMEM/F12 (Cellgro-10-092-CV, Herndon, VA). The
ovaries were punctured with needles to release GCs in DMEM/F12.
The GCs were pelleted at 100 g for 10 min and resuspended at a
density 0.5106 cells/well in DMEM/F12 þ10%FBS. After overnight
culture the cells were stimulated for indicated time points with
DMEM/F12þ recombinant human FSH (LER-4161B) (50 ng/ml-ﬁnal
concentration) (Kind gift from Dr. Anthony Zeleznik) and the cells
were subsequently lysed in 1 Laemmli sample buffer.For lentiviral infections, 106 GCs were centrifuged and then
resuspended in DMEM/F12 containing 8 mg/ml polybrene (hex-
adimethrin bromide—Sigma H9268). The GCs were infected with
lentivirus expressing shRNA constructs to Inpp4b, either
TRCN0000080645 or TRCN0000080646 (Open Biosystems) at an
MOI (multiplicity of infection) of 10 for 2 h following which the
lentivirus-cell suspension was plated in DMEM/F12 þ10%FBS.
After 48 h of culture, the cells were stimulated with DMEM/F12þ
FSH (50 ng/ml) for the indicated times.
Bisulﬁte genomic sequencing
Bisulﬁte genomic sequencing was performed using the EpiTect
Bisulﬁte Kits (Qiagen-59104 Valencia, CA) (Clark et al., 1994).
Following bisulﬁte treatment, the RSV sequence was ampliﬁed with
PCR primers ﬂanking the RSV DMD (within the Ig and c-myc
sequences). Primer sequences are provided in Supplementary Fig. 6.
Real time PCR
RNA was extracted using the RNeasy Micro kit (Qiagen). 1 mg of
RNA was converted to cDNA using the high capacity cDNA reverse
transcription kit (Applied Biosystems, Foster City CA) in a reaction
volume of 20 ml. A volume of 2 ml of the cDNA was used in a 10 ml
Real-time PCR reaction. Real-time PCR was performed using the SYBR
Green master mix (Applied Biosystems) on the 7900HT Fast Real-
Time PCR System machine (Applied Biosystems). Steady-state tran-
script levels were measured by real-time PCR using oligonucleotide
primers located across exons 23 and 24 of Inpp4b mRNA, a region
common to all known forms of Inpp4b transcripts. The Alpha and Beta
isoforms were assayed separately by ampliﬁcation of their alternative
terminal exons. The Pfafﬂ method was used to determine fold
changes and the fold changes were determined as fold change over
wildtype levels (Pfafﬂ, 2001). TATA-binding protein (TBP) (E13.5
embryo studies) and beta glucuronidase (GUSB) (Ovary studies) were
selected as housekeeping control genes. Primer sequences are pro-
vided in Supplementary Fig. 6.
Immunoblot analysis
E13.5 heads, ovaries and ES cell proteins were extracted using a
RIPA lysis buffer supplemented with complete protease inhibitor and
Phosstop phosphatase inhibitor (Roche, Basel, Switzerland). Oocytes
and GCs were lysed in 1 Laemmli sample buffer. Immunoblot
analysis was performed as described previously (Cirio et al., 2008).
Membranes were probed with the following antibodies: INPP4B
(Brain and ES cells—Santa Cruz-sc12318, Santa cruz, CA), INPP4B
(Ovary and GCs—Ferron and Vacher, 2006), Phospho-AKT (Ser-473)
(9271), phospho-FOXO1 (Ser-256) (9461), E2F1 (3742), Cyclin D2
(3741) (Cell Signaling Technology, Beverly, MA) and Actin (Abcam,
Cambridge, MA). The blots were stripped and reprobed with FOXO1
(2880), AKT (9272) (Cell Signaling technology) and P27KIP (Santa cruz-
sc528). Anti-rabbit (GE healthcare: NA934V, Piscataway, NJ) or anti-
goat (sc-2020) secondary antibodies were diluted in blocking solution
(5% milk). Bound antibody was detected using the chemilumines-
cence detection kit ECL Plus (Amersham, Piscataway, NJ). Protein
levels were determined by comparison of intensity on autoradiogra-
phy ﬁlms using the BioSpectrum 500 imager and VisionWorkssLS
analysis software (UVP, LLC, Upland, CA).
BrdU incorporation assay
PD30 mice received an IP injection of 100mg/kg of BrdU (Sig-
ma—B9285) and were killed 2 h after injection. Ovaries were isolated
and the BrdU incorporation was detected by immunohistochemistry
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Ovaries were ﬁxed in 4% PFA and embedded in parafﬁn.
Immunohistochemistry was performed on 5 mm sections using
the Vectastain Elite ABC Kit (Vector laboratories, Burlingame, CA)
according to manufacturer instructions. Mouse anti-BrdU (Sig-
ma—B2531) was used to evaluate cell proliferation and rabbit
anti-cleaved caspase3 (Cell Signaling Technology—9664) was
used to determine the rate of apoptosis in follicles. Immunohis-
tochemistry was performed on four non-adjacent sections and
positive cells were counted in 25 follicles containing a clear
oocyte. Rates of proliferation and apoptosis per follicle were
determined by the number of positive cells in each preantral
(Type 5) and antral follicle divided by the total number of cells in
the follicle.
RNA in situ hybridization (ISH)
Ovaries from 7-week-old mice were dissected in M2 media,
washed in 1 PBS and ﬁxed in fresh 4% paraformaldehyde. PFA-
ﬁxed samples were immersed in 10%, then 20% sucrose in PBS,
followed by OCT embedding. We used digoxigenin-labeled cRNA
probes, synthesized using digoxigenin RNA labeling kit (Roche).
Cryosections (10 mm) of the OCT-embedded placentas were used
for ISH as previously described (Barak et al., 1999). Probes to
Inpp4b isoforms a and b were designed complementary to their
respective alternative terminal exons. Primer sequences used to
amplify probe sequence from Inpp4b cDNA are provided in
Supplementary Fig. 6.
ELISA
P-AKT activation was measured in ES cell lysates using the
PathScans Phospho-Akt1 (Ser473) and Total Akt1 Sandwich
ELISA Kit (Cell signaling: 7160 and 7170) according to manufac-
turer instructions.
Statistical analysis
Each experiment was repeated a minimum of three times.
A mean and standard error was calculated. Signiﬁcance was
assessed using the Wilcoxon Rank-sum test. Results were con-
sidered signiﬁcant (n) if the p value was less than 0.05.Acknowledgements
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